HomeOnline Training HomeApproved ProvidersNational Referral SystemResearchBriefings
Your basket: 0 products    £0.00 View shopping cart
Home
  • NCSCT Shop
    • Vaping Allowed vinyl wall sticker (150x100mm)
    • Vaping Allowed vinyl window sticker - reverse print (150x100mm)
    • Vaping Allowed / No Smoking vinyl window sticker - reverse print (150x100mm)
    • Core competences
    • Very Brief Advice on smoking training DVD
    • 30 Seconds Very Brief Advice on Smoking DVD
    • Very Brief Advice on Secondhand Smoke DVD
    • Good practice for smokefree mental health services
    • Electronic Cigarettes Briefing
    • Standard Treatment Programme
    • Midwifery Briefing
    • Smoking Cessation and Mental Health: a briefing
    • The Smokefree Formula
    • The Champix Briefing – out of print
  • About us
    • Contact us
    • Introducing the NCSCT
    • Privacy Policy
    • Frequently asked questions
  • Support services
    • NCSCT Approved Providers
    • National Referral System
  • Training
    • Training and Assessment Programme
    • NCSCT Mental Health Specialty Module
    • Pregnancy and the Post-Partum Period
    • Very Brief Advice training module
    • Secondhand Smoke training module
    • Face to face training
  • Training resources
    • NCSCT Training Standard
    • Standard treatment programme
  • Stop smoking medications
    • Nicotine Inhalator
    • Nicotine Lozenge
    • Nicotine Microtabs
    • Nicotine Mouth Spray
    • Nicotine Nasal Spray
    • Nicotine Patches
    • Nicotine Strips
    • Nicotine Gum
    • Varenicline (Champix)
    • Bupropion
    • Example varenicline PGD and NRT voucher protocol
  • NCSCT briefings
    • Working with vape shops
    • Mental health briefing
    • Lifestyle service briefing
    • Champix SPC update
    • E-cig briefing V2
    • Prevention v cessation
    • Four week quit rate briefing
    • Smoking Cessation and Mental Health: A briefing for front-line staff
    • Smoking Cessation: a briefing for midwifery staff
    • Quick wins
    • The 'not-a-puff' rule
    • Stop smoking services: increased chances of quitting
    • Cardiovascular disease and Champix
    • Changes to the local stop smoking services quarterly data return for 2014 –15
    • Combination NRT
    • Cost-effectiveness of pharmacotherapy for smoking cessation
    • Managing post-cessation weight gain
    • NCSCT Final Report
    • Smoking and bone health
    • Smoking cessation interventions involving significant others
    • Smoking reduction
    • Stop Smoking Services and Health Inequalities
    • Varenicline: effectiveness and safety
    • Waterpipe tobacco smoking
  • Clinical tools
    • Standard monitoring form
    • Standard Treatment Programme
    • Stop Smoking Service Client Record Form
    • Client Satisfaction Questionnaire
    • Stop Smoking Service Client Satisfaction Questionnaire (full)
    • The Russell Standard
  • Commissioning resources
    • 'Cut Down to Quit' with NRT
    • Competences required for delivering a STP
    • A Toolkit for Commissioners
    • The effectiveness of NHS smoking cessation services: a systematic review
    • ASH SSK
  • Secondary care resources
    • Hospitalised Patients
    • Supporting renal patients
    • Supporting ophthalmology patients
    • Neurology patients
    • Supporting dental patients
    • Stroke patients
    • Rheumatology patients
    • Mental Health Patients
    • Gynaecology patients
    • Ear, nose and throat patients
    • Surgical Patients Factsheet
    • Wound Care Factsheet
    • Orthopedic Patients Factsheet
    • Oncology Patients Factsheet
    • Respiratory Patients Factsheet
    • Pregnant Women Factsheet
    • Paediatrics Factsheet
    • Cardiovascular Patients Factsheet
    • Diabetic Patients Factsheet
  • Research
    • Evidence underpinning NCSCT activities
    • NCSCT publications
  • Research resources
    • Dependence on smoking
    • Health questionnaire
    • Mood and physical symptoms scale (MPSS)
    • Motivation to stop smoking
    • Past quit attempts
    • Physical activity questionnaire
    • Smoking motives
    • Social support
    • Consent form
  • NICE guidance
    • Stop smoking interventions and services
    • Smoking: acute, maternity and mental health servic
    • Tobacco: harm-reduction approaches to smoking (NICE, 2013)
    • Smoking: supporting people to stop smoking
    • How to Stop Smoking in Pregnancy and Following Childbirth (NICE, June 2010)
    • Smokeless tobacco
    • Varenicline for Smoking Cessation (NICE, 2007)
    • Workplace Health Promotion: How to Help Employees to Stop Smoking (NICE, April 2007)
    • Behaviour Change at Population, Community and Individual Levels (NICE, October 2007)
  • Department of Health Guidance
    • Tobacco control delivery plan 2017 to 2022
    • Tobacco Plan 2017-22
    • Local Stop Smoking Services: Service and delivery guidance 2014
    • Service Delivery and Monitoring Guidance: summary
    • The Operating Framework for the NHS in England 2012/13
    • Service Delivery and Monitoring Guidance 2011/12
    • Healthy Lives, Healthy People: A Tobacco Control Plan for England - Summary (March 2011)
    • Healthy Lives, Healthy People Tobacco Control Plan
    • Healthy Lives, Healthy People: strategy
  • Cochrane reviews: behaviour intervention
    • Aversive smoking for smoking cessation
    • Enhancing partner support to improve smoking cessation
    • Exercise interventions for smoking cessation
    • Group behaviour therapy programmes for smoking cessation
    • Individual behavioural counselling for smoking cessation
    • Internet-based interventions for smoking cessation
    • Interventions for promoting smoking cessation during pregnancy
    • Mobile phone-based interventions for smoking cessation
    • Psychosocial interventions for patients with CHD
    • Relapse prevention interventions for smoking cessation
    • Self-help interventions for smoking cessation
    • Smoking cessation for chronic obstructive pulmonary disease
    • Telephone counselling for smoking cessation
  • Cochrane reviews: pharmacological interventions
    • Antidepressants for smoking cessation
    • Anxiolytics for smoking cessation
    • Clonidine for smoking cessation
    • Lobeline for smoking cessation
    • Mecamylamine for smoking cessation
    • Nicobrevin for smoking cessation
    • Nicotine replacement therapy for smoking cessation
    • Opioid antagonists for smoking cessation
  • Cochrane reviews: community interventions
    • Community interventions for reducing smoking among adults
    • Community pharmacy personnel interventions
    • Reducing children's exposure to tobacco
    • Nursing interventions for smoking cessation
    • Physician advice for smoking cessation
    • Quit and Win contests for smoking cessation
    • School-based programmes for preventing smoking
  • Cochrane reviews: interventions in other settings
    • Acupunture and related interventions
    • Biomedical risk assessment as an aid for smoking cessation
    • Hypnotherapy for smoking cessation
    • Interventions for preoperative smoking cessation
    • Interventions for smoking cessation in hospitalised patients
  • Tobacco control statistics
    • Statistical reports



Cochrane reviews: pharmacological interventions

There have been a large number of Cochrane reviews of smoking cessation interventions.

As these are an important resource for the smoking cessation field, we have collected all the reviews covering pharmacological interventions and uploaded them so they can be viewed on our site.

To find out more about the Cochrane reviews that deal with pharmacological interventions, please click on the links below.
Antidepressants for smoking cessation
The aim of this review is to assess the effect of antidepressant medications to aid long-term smoking cessation. ... [More]
Anxiolytics for smoking cessation
The aim of this review is to assess the effectiveness of anxiolytic pharmacotherapy in aiding long term smoking cessation. ... [More]
Clonidine for smoking cessation
The aim of this review is to determine clonidine’s effectiveness in helping smokers to quit. ... [More]
Lobeline for smoking cessation
The objective of this review was to assess the effects of lobeline on long term smoking cessation. ... [More]
Mecamylamine (a nicotine antagonist) for smoking cessation
The objective of this review was to determine the effectiveness of mecamylamine in promoting smoking cessation, either alone or in combination with nicotine replacement therapy. ... [More]
Nicobrevin for smoking cessation
The objective of this review was to assess the effects of Nicobrevin on long term smoking cessation. ... [More]
Nicotine replacement therapy for smoking cessation
The aims of this review were: to determine the effect of NRT compared to placebo in aiding smoking cessation; to consider whether there is a difference in effect for the different forms of NRT; whethe ... [More]
Opioid antagonists for smoking cessation
To evaluate the efficacy of opioid antagonists in promoting long-term smoking cessation. The drugs include naloxone and the longeracting opioid antagonist naltrexone. ... [More]


T&A programme
 
VBA training module
 
SHS training module
 


NCSCT Training and Assessment Programme
Certified Practitioners
Mailing List
contact us (small)
twitter small
facebook small
youtube small
Links to other organisations
Announcements
 
    Need help?

T: 01305 755828

E: enquiries@ncsct.co.uk		 National Centre for Smoking Cessation and Training

Community Interest Company

Registered in England and Wales No. 7394485